WeVote
Log In

Bill

Bill

PR 26-0688

Board of Pharmacy Dr. Jamila Jorden Confirmation Resolution of 2026

26th Council Period (2025-2026) Introduced by Phil Mendelson

Reappoints Dr. Jamila Jorden to the DC Board of Pharmacy as a pharmacist member through March 12, 2029.

Resolution R26-0427, Effective from Jun 30, 2026 Published in DC Register Vol 73 and Page 009430
0
WeVote Research Nonpartisan
Bill Summary · PR 26-0688

Overview

  • Bill: PR 26-0688
  • Session: 26
  • Jurisdiction: District of Columbia
  • Title: Board of Pharmacy Dr. Jamila Jorden Confirmation Resolution of 2026
  • Purpose: Confirm the reappointment of Dr. Jamila Jorden as a pharmacist member of the DC Board of Pharmacy for a term ending March 12, 2029.

Main Purpose and Intent

  • To formally reappoint Dr. Jamila Jorden to the District of Columbia Board of Pharmacy, ensuring continuity of leadership and expertise on the board.
  • The resolution aligns with existing statutory authority governing confirmations for Board of Pharmacy members (Confirmation Act of 1978 and Health Occupations Revision Act of 1985).

Key Provisions and Changes

  • Sec. 2: Confirms the reappointment of Dr. Jamila Jorden as a pharmacist licensed in DC to serve on the Board of Pharmacy. Term specified to end March 12, 2029.
  • Sec. 3: Requires the Council to transmit a copy of the adopted resolution to the nominee and to the Office of the Mayor.
  • Sec. 4: States that the resolution takes effect immediately.

Nominee Details

  • Name: Dr. Jamila Jorden, Pharm.D., MBA, RPh
  • Address: Clinton Street, NE, Washington, DC 20018 (Ward 5)
  • Education:
    • Doctor of Pharmacy, Howard University (2003)
    • Master of Business Administration, Pharmaceutical Management, Drexel University (2013)
  • Licensure:
    • DC Pharmacist License (PH100003514), active since December 2018
    • Pennsylvania, New Jersey pharmacist licenses (active)
  • Professional Experience:
    • Director of Experiential Education, Howard University College of Pharmacy (since 2019)
    • Assistant Director of Experiential Education, Howard University (2018–2019)
    • Prior clinical and pharmacy operations roles at PerformRx and Penn Presbyterian Medical Center
  • Current Roles and Leadership:
    • Active involvement in multiple professional organizations (AACP, NPhA, WMSHP, etc.)
    • Experience in experiential education, curriculum development, precepting, and managed care pharmacy
    • Notable for leadership in ASHP-accredited PGY-1 program and experiential education initiatives

Who Would Be Affected

  • Primary: Dr. Jamila Jorden, in her capacity as a pharmacist board member.
  • The DC Board of Pharmacy would continue to benefit from her expertise in pharmacy education, experiential programs, and managed care pharmacy.
  • Stakeholders include DC pharmacists, colleges of pharmacy, and patients served by DC pharmacies, who rely on the Board’s regulatory and public-protection functions.

Procedural and Timeline Aspects

  • Action History: Referred to Committee on Health on May 19, 2026; introduced May 4, 2026.
  • Confirmation Process: Follows the Council’s confirmation procedure for Board of Pharmacy members under the Confirmation Act of 1978 and Health Occupations Revision Act.
  • Effective Date: Upon adoption of the resolution (immediate effect).
  • Transmission: Upon adoption, a copy of the resolution will be sent to the nominee and to the Mayor’s Office.

Additional Context

  • The Mayor’s letter of nomination and supporting materials provide detailed biographical and professional information intended to assist the Council during confirmation.
  • The nomination indicates ongoing involvement in education, policy, and professional organizations, underscoring the nominee’s qualifications for board service.

If you’d like, I can condense this into a one-paragraph briefing or expand any section with more context from the DC regulatory framework.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.